November 23, 2020

Significant biosimilar activities this week include:

  • 15 Nov 20, US: Genentech filed a complaint against Centus Biotherapeutics, Fujifilm Kyowa Kirin Biologics, Fujifilm Corp and Kyowa Kirin in the Eastern District of Texas, relating to 10 Genentech licensed or owned...

November 19, 2020

19 Nov 20 | US, EU | Alvotech | Alvotech announces the FDA and EMA have accepted its regulatory submissions for AVT02 (proposed adalimumab biosimilar). Approval is expected in the US in September 2021 and Q4 2021 in the EU.

04 Nov 20 | CA | Amgen | Amgen receives three...

Significant biosimilar activities this week include:
 

  • June 28 US: Genentech filed a complaint against Samsung Bioepis in the District Court of Delaware under the BPCIA, alleging infringement of 14 patents related to SB8 (Samsung's proposed bevacizumab biosimil...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags